395 related articles for article (PubMed ID: 32291270)
1. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD.
Steubl D; Schneider MP; Meiselbach H; Nadal J; Schmid MC; Saritas T; Krane V; Sommerer C; Baid-Agrawal S; Voelkl J; Kotsis F; Köttgen A; Eckardt KU; Scherberich JE;
Clin J Am Soc Nephrol; 2020 May; 15(5):616-624. PubMed ID: 32291270
[TBL] [Abstract][Full Text] [Related]
2. Association of serum uromodulin with mortality and cardiovascular disease in the elderly-the Cardiovascular Health Study.
Steubl D; Buzkova P; Garimella PS; Ix JH; Devarajan P; Bennett MR; Chaves PHM; Shlipak MG; Bansal N; Sarnak MJ
Nephrol Dial Transplant; 2020 Aug; 35(8):1399-1405. PubMed ID: 30903163
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Uromodulin With ESKD and Kidney Function Decline in the Elderly: The Cardiovascular Health Study.
Steubl D; Buzkova P; Garimella PS; Ix JH; Devarajan P; Bennett MR; Chaves PHM; Shlipak MG; Bansal N; Sarnak MJ
Am J Kidney Dis; 2019 Oct; 74(4):501-509. PubMed ID: 31128770
[TBL] [Abstract][Full Text] [Related]
4. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
[TBL] [Abstract][Full Text] [Related]
5. Serum uromodulin and risk for cardiovascular morbidity and mortality in the community-based KORA F4 study.
Then C; Then HL; Lechner A; Thorand B; Meisinger C; Heier M; Peters A; Koenig W; Rathmann W; Scherberich J; Seissler J
Atherosclerosis; 2020 Mar; 297():1-7. PubMed ID: 32058862
[TBL] [Abstract][Full Text] [Related]
6. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
7. Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.
Garimella PS; Lee AK; Ambrosius WT; Bhatt U; Cheung AK; Chonchol M; Craven T; Hawfield AT; Jotwani V; Killeen A; Punzi H; Sarnak MJ; Wall BM; Ix JH; Shlipak MG
Eur Heart J; 2019 Nov; 40(42):3486-3493. PubMed ID: 31257404
[TBL] [Abstract][Full Text] [Related]
8. Serum uromodulin is a predictive biomarker for cardiovascular events and overall mortality in coronary patients.
Leiherer A; Muendlein A; Saely CH; Ebner J; Brandtner EM; Fraunberger P; Drexel H
Int J Cardiol; 2017 Mar; 231():6-12. PubMed ID: 28089453
[TBL] [Abstract][Full Text] [Related]
9. Serum Uromodulin and Mortality Risk in Patients Undergoing Coronary Angiography.
Delgado GE; Kleber ME; Scharnagl H; Krämer BK; März W; Scherberich JE
J Am Soc Nephrol; 2017 Jul; 28(7):2201-2210. PubMed ID: 28242751
[TBL] [Abstract][Full Text] [Related]
10. PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function.
Kheirkhah A; Lamina C; Kollerits B; Schachtl-Riess JF; Schultheiss UT; Forer L; Sekula P; Kotsis F; Eckardt KU; Kronenberg F;
Clin J Am Soc Nephrol; 2022 Jun; 17(6):809-818. PubMed ID: 35387881
[TBL] [Abstract][Full Text] [Related]
11. Serum Calcification Propensity and Clinical Events in CKD.
Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
[TBL] [Abstract][Full Text] [Related]
12. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
13. Urinary uromodulin independently predicts end-stage renal disease and rapid kidney function decline in a cohort of chronic kidney disease patients.
Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Kemmner S; Bachmann Q; Angermann S; Wen M; Heemann U; Renders L; Garimella PS; Scherberich J
Medicine (Baltimore); 2019 May; 98(21):e15808. PubMed ID: 31124979
[TBL] [Abstract][Full Text] [Related]
14. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
Rotbain Curovic V; Theilade S; Winther SA; Tofte N; Eugen-Olsen J; Persson F; Hansen TW; Jeppesen J; Rossing P
Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
[TBL] [Abstract][Full Text] [Related]
16. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Liu KD; Yang W; Go AS; Anderson AH; Feldman HI; Fischer MJ; He J; Kallem RR; Kusek JW; Master SR; Miller ER; Rosas SE; Steigerwalt S; Tao K; Weir MR; Hsu CY;
Am J Kidney Dis; 2015 Feb; 65(2):267-74. PubMed ID: 25311702
[TBL] [Abstract][Full Text] [Related]
17. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
Malhotra R; Katz R; Jotwani V; Ambrosius WT; Raphael KL; Haley W; Rastogi A; Cheung AK; Freedman BI; Punzi H; Rocco MV; Ix JH; Shlipak MG
Clin J Am Soc Nephrol; 2020 Mar; 15(3):349-358. PubMed ID: 32111704
[TBL] [Abstract][Full Text] [Related]
18. Plasma ceruloplasmin, a regulator of nitric oxide activity, and incident cardiovascular risk in patients with CKD.
Kennedy DJ; Fan Y; Wu Y; Pepoy M; Hazen SL; Tang WH
Clin J Am Soc Nephrol; 2014 Mar; 9(3):462-7. PubMed ID: 24311705
[TBL] [Abstract][Full Text] [Related]
19. Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.
van der Sande NGC; Visseren FLJ; van der Graaf Y; Nathoe HM; de Borst GJ; Leiner T; Blankestijn PJ;
Clin J Am Soc Nephrol; 2017 Jun; 12(6):921-928. PubMed ID: 28487344
[TBL] [Abstract][Full Text] [Related]
20. Serum Uromodulin Predicts Less Coronary Artery Calcification and Diabetic Kidney Disease Over 12 Years in Adults With Type 1 Diabetes: The CACTI Study.
Bjornstad P; Wiromrat P; Johnson RJ; Sippl R; Cherney DZI; Wong R; Rewers MJ; Snell-Bergeon JK
Diabetes Care; 2019 Feb; 42(2):297-302. PubMed ID: 30482755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
